| About Novartis Vaccines | Products | Pipeline | Press Room | Locations |
These Novartis vaccines have protected millions of children from life-threatening illness.
Diphtheria
Haemophilus Influenzae Type B (Hib)
Meningitis
Pertussis (Whooping Cough)
Polio
Tick-borne Encephalitis (TBE)
Tetanus
NOTE:
Products presented on this website are subject to national regulatory approval, licensing and advertising rules which differ from country to country.
These products may not be approved and/or licensed in all countries where this website is accessible and, with the exception of Fluvirin® and RabAvert®, have not been approved by the U.S. Food and Drug Administration.
In jurisdictions where the presentation and advertising of our products is restricted to members of the medical profession and pharmaceutical organization, such presentation and advertising as are found on this site are not intended for the public and should not be accessed by users who are not members of a medical profession or pharmaceutical organization.
These products, with the exception of Fluvirin® and RabAvert®, are not intended for use by customers, patients or health care professionals in the United States.
Members of the medical profession and pharmaceutical trade are requested not to use this website for any purpose regulated by their respective national laws such as drug approval information, license information, health product promotion or any other purpose for which this international website is not intended.
    |
  |
  |
US Medical Communications is the point of contact for inquiries about our marketed vaccine products, pipeline products, and general vaccine-related questions. Business hours are 8:00am - 5:00pm Eastern Time. Call or submit your question online.
1-800-244-7668
